Skip to content

Research and Development of Key Technologies for Intelligent Minimally invasive and Precise Treatment of Fractures (Project 1: Randomized Controlled Study on Robot-assisted Closed Reduction and Internal Fixation of Intertrochanteric Fractures of the Femur)

Research and Development of Key Technologies for Intelligent Minimally invasive and Precise Treatment of Fractures (Project 1: Randomized Controlled Study on Robot-assisted Closed Reduction and Internal Fixation of Intertrochanteric Fractures of the Femur)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124676
Enrollment
Unknown
Registered
2026-05-15
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intertrochanteric fracture

Interventions

Sponsors

Beijing Jishuitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18 to 80 years old, gender not limited. ; 2.Diagnosed as unilateral, acute, closed intertrochanteric fracture of the femur (AO/OTA 31-A); 3.No more than 21 days from injury to surgery; 4.Before the injury, the individual could walk independently (assistive devices are allowed).

Exclusion criteria

Exclusion criteria: 1. Open fractures or multiple severe traumas that require priority treatment; 2. Asymmetry of both lower extremities or previous ipsilateral femoral malunion affects the assessment of length or rotation; 3. Fractures in other parts on the same side; 4. Pathological fractures (tumors or metabolic bone diseases); 5. Previous complex implants on the same side or previous surgeries have a significant impact on the assessment; 6. Active infections or severe internal diseases that make surgery intolerable; 7. Cognitive impairment, poor compliance, pregnancy or lactation; 8. Those who the researcher deems unsuitable for inclusion in the group (such as those who cannot complete the follow-up); 9. Refuse randomization or refuse to participate in the researcher.

Design outcomes

Primary

MeasureTime frame
The excellent and good rate of closed reduction;

Secondary

MeasureTime frame
Time of operation;Number of X-ray exposures;Peroperative bleeding;Detention time;Fracture healing rate;EQ-5D-5L;HHS Score;

Countries

China

Contacts

Public ContactZhao Chunpeng

Beijing Jishuitan Hospital, Capital Medical University

Zcpllza2008@163.com+86 186 1001 2704

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026